422 related articles for article (PubMed ID: 8530609)
1. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH
J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
[TBL] [Abstract][Full Text] [Related]
2. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
Palermo M; Shackleton CH; Mantero F; Stewart PM
Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
[TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome.
Walker BR; Campbell JC; Fraser R; Stewart PM; Edwards CR
Clin Endocrinol (Oxf); 1992 Dec; 37(6):483-92. PubMed ID: 1337504
[TBL] [Abstract][Full Text] [Related]
4. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease.
Stewart PM; Burra P; Shackleton CH; Sheppard MC; Elias E
J Clin Endocrinol Metab; 1993 Mar; 76(3):748-51. PubMed ID: 8445034
[TBL] [Abstract][Full Text] [Related]
5. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
[TBL] [Abstract][Full Text] [Related]
6. Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.
Torpy DJ; Mullen N; Ilias I; Nieman LK
Ann N Y Acad Sci; 2002 Sep; 970():134-44. PubMed ID: 12381548
[TBL] [Abstract][Full Text] [Related]
7. Hypertension and the cortisol-cortisone shuttle.
Quinkler M; Stewart PM
J Clin Endocrinol Metab; 2003 Jun; 88(6):2384-92. PubMed ID: 12788832
[TBL] [Abstract][Full Text] [Related]
8. Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome.
Ulick S; Wang JZ; Blumenfeld JD; Pickering TG
J Clin Endocrinol Metab; 1992 May; 74(5):963-7. PubMed ID: 1569172
[TBL] [Abstract][Full Text] [Related]
9. [Decreased activity of 11-beta-hydroxysteroid dehydrogenase in patients with Cushing's syndrome].
Stiefel P; Jiménez L; García-Morillo JS; Leal A; Villar J; Carneado J
Med Clin (Barc); 2000 Jun; 115(3):90-2. PubMed ID: 10965482
[TBL] [Abstract][Full Text] [Related]
10. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Agarwal AK
Endocr Rev; 1997 Feb; 18(1):135-56. PubMed ID: 9034789
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
12. Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.
New MI; Stoner E; DiMartino-Nardi J
Clin Exp Hypertens A; 1986; 8(4-5):751-72. PubMed ID: 3463439
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
Stewart PM
Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
[TBL] [Abstract][Full Text] [Related]
14. Androgen secretion in ectopic ACTH syndrome and in Cushing's disease: modifications before and after surgery.
Barbetta L; Dall'Asta C; Re T; Colombo P; Travaglini P; Ambrosi B
Horm Metab Res; 2001 Oct; 33(10):596-601. PubMed ID: 11607879
[TBL] [Abstract][Full Text] [Related]
15. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
16. Human kidney 11 beta-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin?
Diederich S; Quinkler M; Miller K; Heilmann P; Schoneshofer M; Oelkers W
Eur J Endocrinol; 1996 Mar; 134(3):301-7. PubMed ID: 8616526
[TBL] [Abstract][Full Text] [Related]
17. Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.
Vogt B; Dick B; N'Gankam V; Frey FJ; Frey BM
J Clin Endocrinol Metab; 1999 Feb; 84(2):811-4. PubMed ID: 10022459
[TBL] [Abstract][Full Text] [Related]
18. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
19. Apparent cortisone reductase deficiency: a unique form of hypercortisolism.
Phillipov G; Palermo M; Shackleton CH
J Clin Endocrinol Metab; 1996 Nov; 81(11):3855-60. PubMed ID: 8923828
[TBL] [Abstract][Full Text] [Related]
20. Does central obesity reflect "Cushing's disease of the omentum"?
Bujalska IJ; Kumar S; Stewart PM
Lancet; 1997 Apr; 349(9060):1210-3. PubMed ID: 9130942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
